Evidence map›Paper›PMID 32621265›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Demand for weekend outpatient chemotherapy among patients with cancer in Japan.

Hideki Katayama, Masahiro Tabata, Toshio Kubo, Katsuyuki Kiura, Junji Matsuoka, Yoshinobu Maeda

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hideki KatayamaDepartment of Palliative and Supportive Care, Okayama University Hospital, Okayama, Japan. hi_katayama01@yahoo.co.jp.ORCID http://orcid.org/0000-0002-5629-156X
Masahiro TabataDepartment of Palliative and Supportive Care, Okayama University Hospital, Okayama, Japan.
Toshio KuboClinical Cancer Center, Okayama University Hospital, Okayama, Japan.
Katsuyuki KiuraDepartment of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Junji MatsuokaDepartment of Palliative and Supportive Care, Okayama University Hospital, Okayama, Japan.
Yoshinobu MaedaDepartment of Palliative and Supportive Care, Okayama University Hospital, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced cancer therapeutics have improved patient survival, leading to an increase in the number of patients who require long-term outpatient chemotherapy. However, the available schedule options for chemotherapy are generally limited to traditional business hours.

methodIn 2017, we surveyed 721 patients with cancer in Okayama, Japan, regarding their preferences for evening and weekend (Friday evening, Saturday, and Sunday) chemotherapy appointments.

resultsA preference for evening and weekend appointment options was indicated by 37% of the respondents. Patients who requested weekend chemotherapy were younger, female, with no spouse or partner, living alone, employed, and currently receiving treatment. Among these factors, age and employment status were significantly associated with a preference for weekend chemotherapy, according to multivariate analysis.

conclusionOur findings reveal a demand for evening and weekend outpatient chemotherapy, especially among young, employed patients.

Indexed as

AdultAgedAged, 80 and overAppointments and SchedulesFemaleHumansJapanMaleMiddle AgedNeoplasmsOutpatientsCancer patientOutpatientSocial burdenWeekend chemotherapy

Identifiers

PMID32621265
PMCPMC7843541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.